Nordson ($NDSN) Fiscal 2026 Third-Quarter Earnings Analysis — Revenue and Adjusted EPS Top Expectations, Full-Year Guidance Lifted, Shares Up After-Hours
Earnings Scorecard
Revenue: $818 million (+10% year-over-year vs. estimate of $779 million) ✅ Beat
EPS: Adjusted $3.25 (estimate $3.05) ✅ Beat
Guidance: Raised — Full-year revenue $3.035–$3.075 billion, adjusted diluted EPS $11.80–$12.00
Stock reaction: After-hours +7.78% ($334.03) — as of 06:00 KST, Aug 20
Positives
Adjusted EPS beat: Adjusted diluted EPS of $3.25 in fiscal Q3 2026, vs. estimate $3.05 and prior-year adjusted $2.73, a 19% increase
Advanced Technology +31%: Organic revenue in Advanced Technology Solutions jumped on electronic dispensing and test-and-inspection demand
Full-year guidance raised: Lifted to revenue of $3.035–$3.075 billion and adjusted EPS of $11.80–$12.00
Nordson, which makes precision dispensing and fluid-control equipment, posted record quarterly revenue across all three segments, with EBITDA margin holding at 32% of revenue. Backlog rose 35% year-over-year, supporting the revenue trajectory into the fourth quarter.
Negatives
Minority-investment impairment: A non-cash loss on a minority investment weighed on GAAP earnings for the quarter
Industrial Precision growth slows: Organic revenue in Industrial Precision Solutions came in at just +3%
Electronics demand dependence: A large share of the record growth came from Advanced Technology and electronics demand, posing a risk if it cools
GAAP diluted EPS of $2.73 trailed the adjusted figure, requiring a separation of one-time and intangible-amortization items. Medical and Fluid appeared to post lower organic revenue growth, reflecting the impact of the contract-manufacturing divestiture.
What Management Said
CEO Sundaram Nagarajan explained that the first-half momentum carried into the third quarter, exceeding the high end of the prior outlook, and that backlog and new orders put the company on track to surpass $3 billion in annual revenue. The market read these comments as credible support for the raised full-year guidance.
Market Reaction and What to Watch
With record revenue and adjusted EPS beating estimates and full-year guidance moving higher, buyers stepped in aggressively after the close.
Watch whether backlog and new orders translate into fourth-quarter revenue
Monitor whether Advanced Technology (electronic dispensing and test-and-inspection) growth sustains
Track progress toward the full-year adjusted EPS range of $11.80–$12.00
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.